Angiogenesis Inhibitors: all 4,430 studies that test it

Page 16 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.

• A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.CompletedNCT00700102Phase 3Results posted
• A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) PatientsTerminatedNCT00699842Phase 1/2Results posted
• Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver CancerTerminatedNCT00699374Phase 3Results posted
• Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00698815Phase 2Results posted
• A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersCompletedNCT00698451Phase 2Results posted
• Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin LymphomaCompletedNCT00695786Phase 2Results posted
• Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung CancerCompletedNCT00695292Phase 2Results posted
• Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor ResponseCompletedNCT00694096Phase 1Results posted
• Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination ChemotherapyCompletedNCT00693992Phase 3Results posted
• Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance TherapyCompletedNCT00691704Phase 2Results posted
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple MyelomaCompletedNCT00689936Phase 3Results posted
• A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension StudyCompletedNCT00687804Phase 3Results posted
• Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00687674Phase 1Results posted
• Lenalidomide (Revlimid) for the Treatment of Refractory Cancer PainTerminatedNCT00684242Phase 2Results posted
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate CancerCompletedNCT00683475Phase 2Results posted
• Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular EdemaCompletedNCT00682539Phase 4Results posted
• Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)CompletedNCT00681889Phase 1Results posted
• Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal MelanomaCompletedNCT00680225Phase 3Results posted
• Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00679367Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyTerminatedNCT00676650Phase 3Results posted
• Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung CancerCompletedNCT00675597Not applicableResults posted
• Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)TerminatedNCT00675441Phase 2Results posted
• Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerCompletedNCT00675259Phase 2Results posted
• Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal VasculopathyCompletedNCT00674323Phase 4Results posted
• Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau SyndromeTerminatedNCT00673816Phase 1/2Results posted
• FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric CancerCompletedNCT00673673Phase 2Results posted
• Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to ProstatectomyCompletedNCT00672594Phase 2Results posted
• Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)CompletedNCT00671970Phase 2Results posted
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast CancerCompletedNCT00670982Phase 2Results posted
• Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell LymphomaCompletedNCT00670358Phase 1/2Results posted
• CC-4047 in Treating Patients With MyelofibrosisCompletedNCT00669578Phase 1/2Results posted
• Study Of Sunitinib With FOLFIRI In Colorectal CancerCompletedNCT00668863Phase 2Results posted
• Sutent Adjunctive Treatment of Differentiated Thyroid CancerCompletedNCT00668811Phase 2Results posted
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)TerminatedNCT00668785Phase 2Results posted
• Tandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsCompletedNCT00667394Phase 2Results posted
• Phase II Study of Bevacizumab (Avastin®) in MyelofibrosisTerminatedNCT00667277Phase 2Results posted
• Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined SignificanceTerminatedNCT00665652Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• Study Of Sunitinib With Capecitabine In Breast CancerCompletedNCT00662025Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung CancerCompletedNCT00661778Phase 2Results posted
• Use of Ranibizumab With Mitomycin C During TrabeculectomyCompletedNCT00661583Phase 1/2Results posted
• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerCompletedNCT00656669Not applicableResults posted
• Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00655850Phase 2Results posted
• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's LymphomaTerminatedNCT00655668Phase 2Results posted
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00654836Phase 2Results posted
• Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC PatientsCompletedNCT00654186Phase 2Results posted
• Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)TerminatedNCT00651482Phase 2Results posted
• Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma SurgeryTerminatedNCT00644280Not applicableResults posted
• Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)CompletedNCT00642954Phase 1Results posted
• Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00642759Phase 2Results posted
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)CompletedNCT00637377Phase 3Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00633945Not applicableResults posted
• Rituximab, Lenalidomide, and Bortezomib in Mantle Cell LymphomaCompletedNCT00633594Phase 1/2Results posted
• A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast CancerTerminatedNCT00632541Phase 2Results posted
• Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual DiseaseCompletedNCT00632359Phase 2Results posted
• Study Of Sunitinib In Combination With Folfox In Patients With Colorectal CancerCompletedNCT00631410Phase 1Results posted
• Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With ChemotherapyCompletedNCT00627042Phase 2Results posted
• Lucentis Versus Mitomycin C During Glaucoma SurgeryCompletedNCT00626782Phase 2/3Results posted
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the CervixTerminatedNCT00626561Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal CancerCompletedNCT00623805Phase 3Results posted
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerCompletedNCT00623233Phase 2Results posted
• Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityStatus unknownNCT00622726Phase 2Results posted
• Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12TerminatedNCT00622401Phase 1/2Results posted
• A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple MyelomaCompletedNCT00622336Phase 3Results posted
• Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00621686Phase 2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell TransplantCompletedNCT00619684Phase 2Results posted
• A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast CancerCompletedNCT00618826Phase 2Results posted
• Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingCompletedNCT00618657Phase 2Results posted
• Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)CompletedNCT00617591Phase 2Results posted
• Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLCCompletedNCT00616109Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung CancerCompletedNCT00614822Phase 2Results posted
• Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + IrinotecanCompletedNCT00613028Phase 2Results posted
• Ph II Bevacizumab + Etoposide for Pts w Recurrent MGCompletedNCT00612430Phase 2Results posted
• Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and GliosarcomasCompletedNCT00612339Phase 2Results posted
• Phase II Avastin + Bortezomib for Patients With Recurrent Malignant GliomaCompletedNCT00611325Phase 2Results posted
• Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After RituximabCompletedNCT00609869Phase 2Results posted
• Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedNCT00609765Phase 2Results posted
• Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal CancerTerminatedNCT00609622Phase 2Results posted
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerCompletedNCT00608972Phase 2Results posted
• Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine CarcinomaCompletedNCT00607113Phase 2Results posted
• Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field ImagingCompletedNCT00606138Phase 1/2Results posted
• A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and GlioblastomaCompletedNCT00606008Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.CompletedNCT00605722Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)TerminatedNCT00604461Phase 1/2Results posted
• Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple MyelomaCompletedNCT00603447Phase 1Results posted
• Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00602836Phase 2Results posted
• Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT00602641Phase 3Results posted
• Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaCompletedNCT00602459Phase 2Results posted
• Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00601926Phase 2Results posted
• Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00601900Phase 3Results posted
• 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabCompletedNCT00600340Phase 3Results posted
• Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00600028Phase 3Results posted
• Study Of Sunitinib Plus FOLFOX In Patients With Solid TumorsCompletedNCT00599924Phase 1Results posted
• Phase II Sunitinib Prog Met AIPCCompletedNCT00599313Phase 2Results posted
• Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + EverolimusCompletedNCT00597506Phase 2Results posted
• Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasCompletedNCT00597402Phase 2Results posted

← Angiogenesis Inhibitors overview